| Central Nervous System Medulloepithelioma studied in …STUDIED_INderived14 of 14show fewer |
|---|
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581240available An Intermediate Expanded Use Trial of DFMO · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565903completed Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00983398Phase 1/Phase 2 · unknown Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02255461Phase 1 · terminated Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ALIAS · 14 trials mapped (1 active) | — | — | Central Nervous System Medulloepithelioma | 1 | Observed | clinicaltrials | graph → |